Previous 10 | Next 10 |
home / stock / amgn / amgn articles
The FDA has added a serious warning to the prescribing information for Amgen Inc’s (NASDAQ:AMGN) drug Prolia (denosumab), emphasizi...
On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units....
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positionin...
In a recent revelation, CNBC’s Mad Money host Jim Cramer disclosed that the financial market values artificial intelligence (AI) technology m...
Amgen Inc (NASDAQ: AMGN) announced that the FDA has reviewed the company's supplemental New Drug Application, seeking full approval of the...
In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this ar...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this ar...
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...
2024-07-12 12:30:05 ET UBS analyst issues NEUTRAL recommendation for AMGN on July 12, 2024 10:22AM ET. The previous analyst recommendation was Neutral. AMGN was trading at $331.355 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...